Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| 1 |
AbbVie
ABBV
|
+$825M |
| 2 |
NextEra Energy, Inc.
NEE
|
+$654M |
| 3 |
Broadcom
AVGO
|
+$647M |
| 4 |
Home Depot
HD
|
+$641M |
| 5 |
PPL Corp
PPL
|
+$448M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$784M |
| 2 |
Texas Instruments
TXN
|
+$749M |
| 3 |
Merck
MRK
|
+$431M |
| 4 |
Constellation Energy
CEG
|
+$416M |
| 5 |
Tesla
TSLA
|
+$386M |
Sector Composition
| 1 | Technology | 28.16% |
| 2 | Healthcare | 14.3% |
| 3 | Financials | 10.49% |
| 4 | Industrials | 9.8% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Pembina Pipeline
PBA
$22.5B
| $33.3M | 0.01% |
897,038
+48,346
| +6% | +$1.79M |
|
652
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $33.2M | 0.01% |
429,214
+4,388
| +1% | +$339K |
|
653
Eagle Materials
EXP
$7.49B
| $33.1M | 0.01% |
152,404
-5,300
| -3% | -$1.15M |
|
654
Bombardier Recreational Products
DOOO
$4.69B
| $33.1M | 0.01% |
516,642
+316,352
| +158% | +$20.3M |
|
655
StepStone Group
STEP
$4.81B
| $33M | 0.01% |
719,291
+347,858
| +94% | +$16M |
|
656
Bio-Rad Laboratories Class A
BIO
$7.49B
| $33M | 0.01% |
120,712
+48,289
| +67% | +$13.2M |
|
657
Procept Biorobotics
PRCT
$2.09B
| $32.9M | 0.01% |
538,662
+432,803
| +409% | +$26.4M |
|
658
Cable One
CABO
$893M
| $32.9M | 0.01% |
92,810
+92,707
| +90,007% | +$32.8M |
|
659
MGIC Investment
MTG
$6.54B
| $32.8M | 0.01% |
1,523,469
+20,208
| +1% | +$435K |
|
660
Vanguard Growth ETF
VUG
$188B
| $32.8M | 0.01% |
87,668
-4,566
| -5% | -$1.71M |
|
661
Kinsale Capital Group
KNSL
$9.92B
| $32.7M | 0.01% |
84,995
+1,168
| +1% | +$450K |
|
662
Flywire
FLYW
$1.62B
| $32.7M | 0.01% |
1,996,443
+290,484
| +17% | +$4.76M |
|
663
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$3.7B
| $32.7M | 0.01% |
1,373,400
+165,000
| +14% | +$3.92M |
|
664
Ryerson Holding
RYI
$707M
| $32.6M | 0.01% |
1,671,773
+547,190
| +49% | +$10.7M |
|
665
Illumina
ILMN
$14.7B
| $32.5M | 0.01% |
311,812
-22,139
| -7% | -$2.31M |
|
666
BioMarin Pharmaceuticals
BMRN
$10.5B
| $32.4M | 0.01% |
393,912
+75,864
| +24% | +$6.25M |
|
667
Huron Consulting
HURN
$2.36B
| $32.4M | 0.01% |
328,549
+315,173
| +2,356% | +$31M |
|
668
Archer Daniels Midland
ADM
$29.5B
| $32.3M | 0.01% |
534,803
+417,754
| +357% | +$25.3M |
|
669
Kura Oncology
KURA
$709M
| $32.2M | 0.01% |
1,565,288
-9,958
| -0.6% | -$205K |
|
670
Mirum Pharmaceuticals
MIRM
$3.76B
| $32.2M | 0.01% |
941,570
+196
| +0% | +$6.7K |
|
671
TC Energy
TRP
$54B
| $32.2M | 0.01% |
848,554
+4,340
| +0.5% | +$165K |
|
672
Lennar Class A
LEN
$35.4B
| $32.1M | 0.01% |
220,933
-8,037
| -4% | -$1.17M |
|
673
Syndax Pharmaceuticals
SNDX
$1.36B
| $31.9M | 0.01% |
1,555,234
+59,529
| +4% | +$1.22M |
|
674
EyePoint Pharmaceuticals
EYPT
$934M
| $31.8M | 0.01% |
3,649,649
+260,412
| +8% | +$2.27M |
|
675
Equitable Holdings
EQH
$15.8B
| $31.5M | 0.01% |
771,963
+103,917
| +16% | +$4.25M |
|